Restoring logic and data to phage-cures for infectious disease

Area of Science:

• Microbiology
• Virology
• Infectious Diseases

Background:

• Antibiotic resistance in bacteria (superbugs) is a growing threat to infectious disease treatment.
• Phage therapy, using bacteriophages (phages), offers a complementary approach to antibiotics.
• Phage therapy utilizes cocktails of phages to overcome bacterial resistance, which is rapid and not exhaustible.

Purpose of the Study:

• To highlight the established success of phage therapy using stockpiled environmental phages.
• To identify key areas for optimizing phage therapy research and development.
• To advocate for a research track focused on practical phage stockpile utilization.

Main Methods:

• Utilizing stockpiles of stored environmental phages to create therapeutic cocktails.
• Adding new phages to stockpiles as needed to counter evolving bacterial resistance.
• Focusing on optimizing phage detection, purification, storage, and characterization.
• Employing directed evolution to enhance phage efficacy in the presence of bacteriostatic compounds.
• Leveraging phage genome sequencing and bioinformatics for improved characterization.
• Developing database technology for efficient information management and phage retrieval.

Main Results:

• Phage therapy using stockpiled phages has a proven track record, including a significant human therapy success.
• Current research trends are not optimally aligned with the successful application of phage therapy via stockpiles.
• A strong case exists for redirecting research efforts towards practical, stockpile-based phage therapy.

Conclusions:

• Phage therapy is a viable and effective strategy against antibiotic-resistant bacteria.
• Optimizing phage stockpiles and associated technologies is essential for real-world success.
• A shift in research focus is needed to accelerate the clinical translation of phage therapy.